DJCOMEDIUM SIGNALFINANCIAL10-K

DJCO demonstrated strong financial performance with substantially higher net income and a meaningful expansion in cash position, while reducing capital expenditures and inventory levels.

The company's balance sheet strengthened considerably with cash rising 58% to $20.6M and stockholders' equity growing over 40% to $391M, indicating robust capital generation. However, the substantial reduction in capital expenditures and inventory drawdowns may signal either operational efficiency improvements or potential concerns about future investment in the business.

Comparing 2025-12-29 vs 2024-12-31View on EDGAR →
FINANCIAL ANALYSIS

DJCO's financial position improved meaningfully across key metrics, with total assets expanding 36% to $548M driven by higher cash levels and stockholders' equity growth of 40%. Net income grew substantially while SG&A expenses increased notably, suggesting strong underlying business performance despite higher operating costs. The dramatic reductions in capital expenditures and inventory levels indicate either strategic cash conservation or reduced operational requirements, contributing to the company's strengthened liquidity position.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
-83.7%
$49K$8K

Capex reduced 83.7% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Inventory
Balance Sheet
-79.2%
$72K$15K

Inventory drawn down 79.2% — strong sell-through or deliberate destocking; watch for supply constraints.

Cash & Equivalents
Balance Sheet
+58.4%
$13.0M$20.6M

Cash position surged 58.4% — strong cash generation or capital raise providing significant financial cushion.

SG&A Expense
P&L
+45.9%
$23.2M$33.8M

SG&A up 45.9% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Net Income
P&L
+43.6%
$78.1M$112.1M

Net income grew 43.6% — bottom-line growth signals improving overall business health.

Stockholders Equity
Balance Sheet
+40.3%
$278.8M$391.1M

Equity base grew 40.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Current Assets
Balance Sheet
+36.7%
$394.5M$539.2M

Current assets grew 36.7% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
+35.8%
$403.8M$548.1M

Asset base grew 35.8% — expansion through organic growth, acquisitions, or capital deployment.

Total Liabilities
Balance Sheet
+25.7%
$125.0M$157.1M

Liabilities increased 25.7% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2025-12-29
PRIOR — 2024-12-31
ADDED
As of December 16, 2025, there were outstanding 1,377,722 shares of Common Stock.
Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 17 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 18 Item 7A.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 46 Item 9A.
+7 more — sign up free →
REMOVED
As of November 30, 2024, there were outstanding 1,377,026 shares of Common Stock.
At September 30, 2024, the Los Angeles Daily Journal had approximately 3,805 paid subscribers and the San Francisco Daily Journal had approximately 2,177 paid subscribers as compared with total paid subscriptions for both of The Daily Journals of 5,653 at September 30, 2023.
The gross revenues generated directly by The Daily Journals are attributable approximately 54% to subscriptions and 46% to the sale of advertising and other revenues.
Revenues from The Daily Journals constituted approximately 11% of the Company's total operating revenues in both fiscal 2024 and 2023.
The Orange County Reporter ( Reporter ) has been an adjudicated newspaper of general circulation since 1922.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →